Skip to main content
SpringerLink
Log in

Cytochrome P450 1A1 (CYP1A1) polymorphism and susceptibility to esophageal cancer: an updated meta-analysis of 27 studies

  • Research Article
  • Published:
Tumor Biology

Abstract

Cytochrome P450 1A1 (CYP1A1) polymorphisms are known to play a crucial role in the development and metastasis of malignant diseases including esophageal cancer. However, the results of previous studies investigating the association between CYP1A1 polymorphisms and esophageal cancer risk have been inconsistent. This meta-analysis of 27 eligible studies, encompassing 4,215 esophageal cancer cases and 6,339 control subjects, pooled the odds ratios (ORs) with corresponding 95 % confidence intervals (95 % CI) to assess this association. The effects of ethnicity (Caucasian and Asian) and histopathology type (esophageal squamous cell carcinoma and esophageal adenocarcinoma) were considered in subgroup analyses. A significant association was observed between the CYP1A1 Ile/Val gene polymorphism and esophageal cancer in all of the genetic models (Ile/Val vs. Ile/Ile, OR = 1.41, 95 % CI = 1.25–1.58; Val/Val vs. Ile/Ile, OR = 1.94, 95 % CI = 1.34–2.82; Ile/Val + Val/Val vs. Ile/Ile, OR = 1.49, 95 % CI = 1.33–1.66). The subgroup analysis based on ethnicity showed that the association between the CYP1A1 Ile/Val polymorphism and esophageal cancer existed in Asian and Caucasian populations. However, no association was observed between the CYP1A1 MspI polymorphism and esophageal cancer in either subgroup or in the overall population. These results suggested that the CYP1A1 Ile/Val polymorphism was associated with an increased risk of esophageal cancer, whereas the CYP1A1 MspI polymorphism may not have increased susceptibility to esophageal cancer. Further studies are required to confirm these findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Kim T, Grobmyer SR, Smith R, et al. Esophageal cancer—the five year survivors. J Surg Oncol. 2011;103:179–83.

    Article  PubMed  Google Scholar 

  2. Bergheim I, Wolfgarten E, Bollschweiler E, et al. Cytochrome P450 levels are altered in patients with esophageal squamous-cell carcinoma. World J Gastroenterol. 2007;13:997–1002.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Wu K, Li K. Association between esophageal cancer and drought in China by using geographic information system. Environ Int. 2007;33:603–8.

    Article  PubMed  Google Scholar 

  4. Gignoux M, Launoy G. Recent epidemiologic trends in cancer of the esophagus. Rev Prat. 1999;49:1154–8.

    CAS  PubMed  Google Scholar 

  5. Chen X, Yang CS. Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis. 2001;22:1119–29.

    Article  CAS  PubMed  Google Scholar 

  6. Hongo M, Nagasaki Y, Shoji T. Epidemiology of esophageal cancer: oriento occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol. 2009;24:729–35.

    Article  PubMed  Google Scholar 

  7. Cheung WY, Liu G. Genetic variations in esophageal cancer risk and prognosis. Gastroenterol Clin N Am. 2009;38:75–91.

    Article  Google Scholar 

  8. Wang L, Yang H, Fan Z, et al. Cytological screening and 15 years’ follow-up (1986-2001) for early esophageal squamous cell carcinoma and precancerous lesions in a high-risk population in Anyang County, Henan Province. North China Cancer Detect Prev. 2005;29:317–22.

    Article  CAS  Google Scholar 

  9. Agundez JA. Cytochrome P450 gene polymorphism and cancer. Curr Drug Metab. 2004;5:211–24.

    Article  CAS  PubMed  Google Scholar 

  10. Quiñones L, Gil L. Induction of rat hepatic cytochrome P450 1A1 isozyme by organic extracts from airborne particulate matter. Xenobiotica. 1995;25:571–9.

    Article  Google Scholar 

  11. Guengerich FP, Shimada T. Activation of procarcinogens by human cytochrome P450 enzymes. Mutat Res. 1998;400:201–13.

    Article  CAS  PubMed  Google Scholar 

  12. Rojas M, Cascorbi I, Alexandrov K, et al. Modulation of benzo[a] pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism. Carcinogenesis. 2000;21:35–41.

    Article  CAS  PubMed  Google Scholar 

  13. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta analysis. BMJ. 2003;327:557–60.

    Article  PubMed Central  PubMed  Google Scholar 

  14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  CAS  PubMed  Google Scholar 

  15. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.

    CAS  PubMed  Google Scholar 

  16. Egger M, Davey Smith G, Schneider M, Minder C. Bias inmeta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34

  17. Zhang H, Sun C, Li L, Yan M. Cytochrome P4501A1 and the genetic susceptibility to esophageal carcinoma. Chin J Prev Med. 2000;34:69–71 (in Chinese).

    CAS  Google Scholar 

  18. Shao G, Su Y, Huang G, Wen B. Relationship between CYP1A1, GSTM1 genetic polymorphism and susceptibility to esophageal squamous cell carcinoma. Chin J Epidemiol. 2000;21:420–3 (in Chinese).

    CAS  Google Scholar 

  19. Yang J, Yang R, Li H, Wen P, Jin S. Study of a CYP1A1 genotype associated with susceptibility to esophageal cancer. Chin J Clin Oncol Rehabil. 2004;11:9–11 (in Chinese).

    Google Scholar 

  20. Han Y, Feng X, Li P, Niu Z. Case-control study on relationship of CYP1A1 and GSTM1 polymorphism and susceptibility to esophageal squamous carcinoma. Chin J Public Health. 2005;21:3–6 (in Chinese).

    CAS  Google Scholar 

  21. Morita S, Yano M, Shiozaki H, et al. CYP1Al, CYP2E1 and GSTMl polymorphism are not associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer. 1997;71:192–5.

    Article  CAS  PubMed  Google Scholar 

  22. Hori H, Kawano T, Endo M, et al. Genetic polymorphism of tobacco and alcohol-related metabolizing enzymes and human esophageal squamous cell carcinoma susceptibility. J Clin Gastroenterol. 1997;25:568–75.

    Article  CAS  PubMed  Google Scholar 

  23. Nimura Y, Yokoyama S, Fujimori M, et al. Genotyping of the CYPlA1 and GSTMI genes in esophageal carcinoma patients with special reference to smoking. Cancer. 1997;80:852–7.

    Article  CAS  PubMed  Google Scholar 

  24. Wu MT, Lee JM, Wu DC, et al. Genetic polymorphism of cytochrome P4501A1 and oesophageal squamous-cell carcinoma in Taiwan. Brit J Cancer. 2002;87:529–32.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Wang L, Zheng S, Liu B, et al. CYP1A1, GSTs and mEX polymorphism and susceptibility high-incidence esophageal carcinoma: study of population from area in north China. World J Gastroenterol. 2003;9:1394–7.

    CAS  PubMed  Google Scholar 

  26. Wang A, Sun C, Li L, et al. Genetic susceptibility and environmental factors of esophageal cancer in Xi’an. World J Gastroenterol. 2004;10:940–4.

    PubMed  Google Scholar 

  27. Deng J, Guo R, Yue H, et al. A case-control study of the polymorphisms of phase I and phase II metabolic genes and esophageal carcinoma susceptibility. Pract J Card Cereb Pneumal Vasc Dis. 2008;16:16–7.

    CAS  Google Scholar 

  28. Yin D, Zhang G, Deng Y, Ma Y, Ju L, Chen Y. CYP1A1, GSTM1 genetic polymorphism and their combined role in susceptibility of esophageal cancer. Cancer Detect Prev. 2010;37:712–6 (in Chinese).

    CAS  Google Scholar 

  29. Wang D, Su M, Tian D, Liang S, Zhang J. Associations between CYP1A1 and CYP2E1 polymorphism and susceptibility to esophageal cancer in chaoshan and taihang areas of China. Cancer Epidemiol. 2012;36:276–82.

    Article  CAS  PubMed  Google Scholar 

  30. Yun Y, Wang Y, Wang P, et al. CYP1A1 genetic polymorphism and risk for esophageal cancer: a case-control study in central china. Asian Pac J Cancer Prev. 2013;14:6507–12.

    Article  Google Scholar 

  31. Bhat GA, Shah IA, Makhdoomi MA, et al. CYP1A1 and CYP2E1 genotypes and risk of esophageal squamous cell carcinoma in a high-incidence region, Kashmir. Tumour Biol. 2014;8.

  32. Van Lieshout EM, Roelofs HM, Dekker S, et al. Polymorphic expression of the glutathione S-transferase P1 gene and its susceptibility to Barrett’s esophagus and esophageal carcinoma. Cancer Res. 1999;59:586–9.

    PubMed  Google Scholar 

  33. Abbas A, Delvinquiere K, Lechevrel M, et al. GSTM1, GSTT1, GSTP1 and CYP1A1 genetic polymorphisms and susceptibility to esophageal cancer in a French population: different pattern of squamous cell carcinoma and adenocarcinoma. World J Gastroenterol. 2004;10:3389–93.

    CAS  PubMed  Google Scholar 

  34. Louise W, Thomas L, Federico M, et al. GST, NATl, CYPlAl polymorphism and risk of esophageal and gastric adenocarcinomas. Cancer Detect Prev. 2007;31:233–6.

    Article  Google Scholar 

  35. Casson AG, Zheng Z, Chiasson D, et al. Associations between genetic polymorphisms of Phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma. Cancer Detect Prev. 2003;27:139–46.

    Article  CAS  PubMed  Google Scholar 

  36. Zhu S, Feng X, Li P. Relationship of the polymorphism of CYP1A1 and SULT1A1 genes and susceptibility to esophageal carcinoma. 2005; Master's Thesis, Shanxi Medical University. (in Chinese).

  37. Yin L, Pu Y, Song Y, et al. Polymorphism of susceptible genes for esophageal cancer risk in Huaian population in Jiangsu Province. Tumor. Jul. 2005;25:357–61 (in Chinese).

  38. Lu H, Yang L, Li F. Genetic polymorphism of CYP1A1 MspI associated with susceptibility to esophageal cancer in the Kazakans. Nong Ken Med. 2006;28:81–3 (in Chinese).

    CAS  Google Scholar 

  39. Jain M, Kumar S, Ghoshal UC, et al. CYP1A1 MspI T/C polymorphism in esophageal cancer: no association and risk modulation. Oncol Res. 2007;16:437–43.

    CAS  PubMed  Google Scholar 

  40. Ji R, Wu J, Zhou Y, Zhang B, et al. Relationship between CYP1A1, GSTM1 and GSTT1 genetic polymorphism and susceptibility of esophageal cancer in Wuwei, Gansu province. J Lanzhou Univ (Med Sci). 2010;36:29–34 (in Chinese).

    CAS  Google Scholar 

  41. Malik MA, Upadhyay R, Mittal RD, et al. Association of xenobiotic metabolizing enzymes genetic polymorphism with esophageal cancer in Kashmir Valley and influence of environmental factors. Nutr Cancer. 2010;62:734–42.

    Article  CAS  PubMed  Google Scholar 

  42. Tian Y, Gao P. The relationship between CYP1A1, GSTTI and GSTM1 genetic polymorphism and susceptibility of Ningxia Hui People esophageal carcinoma. Ningxia Med J. 2012;34:196–9 (in Chinese).

    Google Scholar 

  43. Huang X, Tan Z, Zhang Y. The relationship between CYP1A1, MspI genetic polymorphism and susceptibility of Guangxi Zhuang People esophageal carcinoma. J Guangxi Med Univ. 2012;29:224–6 (in Chinese).

    CAS  Google Scholar 

  44. Wu C, Kraft P, Zhai K, et al. Genome-wide association analysis of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions. Nat Genet. 2012;44:1090–7.

    Article  CAS  PubMed  Google Scholar 

  45. Umar SB, Fleischer DE. Esophageal cancer: epidemiology, pathogenesis and prevention. Nat Clin Pract Gastroenterol Hepatol. 2008;5:517–26.

    Article  Google Scholar 

  46. Tran GD, Sun XD, Abnet CC, et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer. 2005;113:456–63.

    Article  CAS  PubMed  Google Scholar 

  47. Lin K, Shen W, Shen Z, et al. Dietary exposure and urinary excretion of total N-nitroso compounds, nitrosamino acids and volatile nitrosamine in inhabitants of high- and low-risk areas for esophageal cancer in southern China. Int J Cancer. 2002;102:207–11.

    Article  CAS  PubMed  Google Scholar 

  48. Acevedo C, Opazo JL, Huidobro C, et al. Positive correlation between single or combined genotypes of CYP1A1 and GSTM1 in relation to prostate cancer in Chilean people. Prostate. 2003;57:111–7.

    Article  CAS  PubMed  Google Scholar 

  49. Lei D, Pan X, Guo C. Genetic polymorphism of cytochrome P4501A1 and susceptibility to laryngeal carcinoma. Chin J Otolaryngol. 2002;37:373–6.

    Google Scholar 

  50. Tsuchiya Y, Sato T, Kiyohara C, et al. Genetic polymorphism of cytochrome P4501A1 and risk of gallbladder cancer. J Exp Clin Cancer Res. 2002;21:119–24.

    CAS  PubMed  Google Scholar 

  51. Sobti RC, Sharma S, Joshi A, et al. CYP1A1 and CYP2D6 polymorphism and risk of lung cancer in a North Indian population. Biomarkers. 2003;8:415–28.

    Article  CAS  PubMed  Google Scholar 

  52. Zhuo W, Zhang Y, Wang Y, et al. Association studies of CYP1A1 and GSTM1 polymorphism with esophageal cancer risk: evidence-based meta-analysis. Arch Med Res. 2009;40:169–79.

    Article  CAS  PubMed  Google Scholar 

  53. Shen F, Zhou F, Xue Q, et al. Association between CYP1A1 polymorphisms and esophageal cancer: a meta-analysis. Mol Biol Rep. 2013;40:6035–42.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Epidemiology and Health Statistics, School of Public Health, Anhui Medical University, No. 81 Meishan Road, Hefei, 230032, Anhui, China

    Feng-Feng Gong, Shan-Shan Lu, Cai-Yun Hu, Zhen-Zhong Qian, Fang Feng, Yi-Le Wu, Hui-Yun Yang & Ye-Huan Sun

  2. Centre for Evidence-Based Practice, Anhui Medical University, No. 81 Meishan Road, Hefei, 230032, Anhui, China

    Ye-Huan Sun

Authors
  1. Feng-Feng Gong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shan-Shan Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cai-Yun Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhen-Zhong Qian
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fang Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yi-Le Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hui-Yun Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ye-Huan Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ye-Huan Sun.

Additional information

F.-F. Gong and S.-S. Lu contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gong, FF., Lu, SS., Hu, CY. et al. Cytochrome P450 1A1 (CYP1A1) polymorphism and susceptibility to esophageal cancer: an updated meta-analysis of 27 studies. Tumor Biol. 35, 10351–10361 (2014). https://doi.org/10.1007/s13277-014-2341-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2341-y

Keywords

Search

Navigation